Recent SONN News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 02:05:59 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 01:48:17 PM
- Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates • GlobeNewswire Inc. • 02/19/2025 01:35:00 PM
- Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference • GlobeNewswire Inc. • 02/18/2025 02:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2025 09:15:23 PM
- Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer • GlobeNewswire Inc. • 02/13/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2025 01:09:06 PM
- Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update • GlobeNewswire Inc. • 02/13/2025 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/03/2025 05:15:13 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/31/2025 09:57:21 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/31/2025 09:56:21 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/30/2025 10:25:42 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/30/2025 10:25:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2025 02:10:11 PM
- Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform Technology • GlobeNewswire Inc. • 01/28/2025 02:05:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2025 09:15:46 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2025 09:11:14 PM
- Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar • GlobeNewswire Inc. • 01/22/2025 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 02:17:30 PM
- Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas • GlobeNewswire Inc. • 01/21/2025 02:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/21/2025 01:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/13/2025 09:34:28 PM
FEATURED Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • Mar 10, 2025 9:05 AM
North Bay Resources Announces Assays up to 5.69% Copper, 1 Opt. Silver, and 0.22% Vanadium at Copper Island Project, British Columbia • NBRI • Mar 10, 2025 9:00 AM
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare • AVAI • Mar 10, 2025 8:00 AM
Veri Medtech (VRHI) Network Grows To 400 Physicians • VRHI • Mar 10, 2025 7:32 AM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM
Authentic Holdings To Reduce Debt by over $2 Million While Achieving Substantial Revenue Growth • AHRO • Mar 6, 2025 8:00 AM